Navigation Links
DiaLog Signs Agreement with DeliverMed to Improve Diabetic Patient Management
Date:7/29/2008

WILMINGTON, N.C., July 29 /PRNewswire/ -- DiaLog, Inc., a wholly owned subsidiary of Inclinix, Inc., signed a joint agreement with DeliverMed Holdings, LLC, an Illinois-based, diabetes specialty home delivery pharmacy. DiaLog's featured product, the DiaLog System, promotes compliance and adherence to blood glucose testing to help diabetic patients and their physicians better manage their disease. DeliverMed complements the DiaLog System as a leading delivery supplier of prescription medications and glucose testing supplies across the U.S.

The DiaLog System and DeliverMed's services will give physicians the single source for glucose monitoring results and prescription fulfillment information to measure patient compliance and progress. Use of the DiaLog System by DeliverMed's patients will result in enhanced compliance to prescribed therapies, improved patient outcomes and related cost savings.

The CDC recently reported nearly 24 million people in the U.S. suffer from diabetes, an increase of more than three million in two years. With this rapidly growing prevalence, it is critical to the U.S. health system to provide effective tools to better manage the disease. The DiaLog System and DeliverMed's home delivery service will provide patients a "one source" for glucose monitoring, prescription fulfillment and patient education.

Jeff Bagshaw, President of DiaLog and Senior VP of Inclinix stated, "DiaLog is a powerful, convenient system for patients and physicians to improve the quality of life for diabetic patients. The addition of DeliverMed to the DiaLog system will allow us to provide easily accessible prescription drugs and supplies to diabetics."

About DeliverMed

Founded in 1998, DeliverMed provides prescription medications and glucose testing supplies to the homes of individuals suffering from diabetes and other chronic conditions. DeliverMed combines the latest in pharmacy robotic technology with old-fashioned personal customer service to provide the highest quality patient care. DeliverMed provides its services at no additional cost to either patients or insurers. For more information on DeliverMed, contact CEO, Mark A. Swift.

About Inclinix

Founded in 1999, Inclinix provides strategic medical marketing communications and adherence services to the healthcare industry. Inclinix delivers customized marketing solutions that yield improved market penetration and adherence results. In the pharmaceutical development arena, Inclinix is a contract research organization that supports and manages clinical drug trials and patient recruitment. For more information about Inclinix, visit http://www.inclinix.com .

Press Contacts:

Mark A. Swift

DeliverMed

Chief Executive Officer

312.543.5450

delivermed@yahoo.com

Jeff Bagshaw

Inclinix

Senior VP of Inclinix

910.332.2066

jbagshaw@inclinix.com


'/>"/>
SOURCE Inclinix, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Coalition to Prevent Deep-Vein Thrombosis (DVT) Seeks New Icon to Raise Awareness and Increase Dialogue
2. Online tool supports more dialogue on prostate cancer risk
3. Health Dialog and Independence Blue Cross Extend Relationship, Expand Services
4. Canadian Pacific and Mayo Clinic Build Understanding and Commit to Ongoing Dialogue
5. Free Site Offering Patient-Physician Dialog Reaches Milestone
6. CIDM Collaborates With World Congress to Advance Dialog on Online Provider Networks at WHIT 3.0
7. Data Dialog Marketing Expands Sales Management Team
8. British Council and Los Angeles Area Universities Partner to Host Transatlantic Dialogues
9. Streamline Health(R) Signs Catholic Healthcare West for Integrated Document Workflow Solutions
10. iNutrition Signs John OHurley to Launch New Internet Video Campaign
11. Huntsville Hospital Signs With Health Care Systems, Inc. for Automated Medication Reconciliation Services
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/20/2017)... ... ... As a leading dental practice, Wall Centre Dental supports Stroke Awareness Month ... bleeding gums in Vancouver, BC, may be developing gingivitis, the first stage of ... and diabetes. Drs. Parviz Roshan, Siamak Tehrani and Milton Reskovich offer laser gum therapy ...
(Date:6/20/2017)... ... June 20, 2017 , ... This year, participants in the ... finding product improvements that could reduce the occurrence of unplanned extubations (UEs). ... breathing or to provide medication. Sometimes, patient movement can cause unplanned extubations which ...
(Date:6/20/2017)... ... June 20, 2017 , ... Uniform Advantage ... featuring seven new products designed to create tailored looks and athleisure-inspired outfits. UA Flex ... cotton easy care stretch twill. , With trendy looks hitting the medical community, UA ...
(Date:6/20/2017)... ... , ... John D'Eri, CEO of Rising Tide Car Wash , will ... during the Autism Society of America 's 49th annual conference to be held ... (DJFF) was founded in 2002 as the nation's first autism organization focused exclusively ...
(Date:6/20/2017)... ... June 20, 2017 , ... International water ... The Sharon Kleyne Hour Power of Water, Global Climate Change and Your Health ... world’s water crisis and how it affects the human eyes. , According ...
Breaking Medicine News(10 mins):
(Date:6/9/2017)... , June 9, 2017 AirXpanders, Inc. ... focused on the design, manufacture, sale and distribution of ... on the progress of its commercial roll-out in ... available in more than one hundred (100) medical institutions ... AeroForm offers a needle-free alternative for women who ...
(Date:6/7/2017)... -- Endo International plc (NASDAQ: ENDP ) ... Joseph R. Goodwin , U.S. District Court Judge for ... , entered a case management order in MDL 2325, ... Litigation (the "MDL") that includes a provision requiring plaintiffs ... on specific causation within one hundred twenty (120) days ...
(Date:6/3/2017)... June 3, 2017  Eli Lilly and Company ... results from the Phase 3 MONARCH 2 study ... 6 inhibitor, in combination with fulvestrant, significantly improved ... alone in women with hormone-receptor-positive (HR+), human epidermal ... who have relapsed or progressed after endocrine therapy ...
Breaking Medicine Technology: